ArticleCurrent drug targets2026

Cytokeratin 8 as a Novel Therapeutic Target in Type 2 Diabetes Mellitus: Suppression of Hepatic Glycogen Synthesis via IRS1/PI3K/Akt/GSK3β Signaling.

Mingzhu Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.